Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07088588 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of SYN608 for the Treatment of Advanced or Metastatic Solid Tumors

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This interventional study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of SYN608 as monotherapy in adult patients with advanced solid tumors
Trial Details
NCT Number NCT07088588
Lead Sponsor Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
Conditions
(from sponsor)		 Advanced Solid Cancer, Metastatic Solid Tumor, Ovarian Cancer, Breast Cancer, BRCA Mutation, HRR Deficiency
Related terms Breast Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms
Enrollment 105 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov